Influence of a patient information program on adherence and persistence with an aromatase inhibitor in breast cancer treatment—the COMPAS study

Adherence to medication.

Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974 · see citing works

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Howell, A., Cuzick, J. M., Baum, M., Buzdar, A. U., Dowsett, M., Forbes, J., Hoctin-Boes, G., Houghton, J., Locker, G. Y., & Tobias, J. S. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17666-6 · Cited by 2,284 · see citing works

Medication compliance and persistence: terminology and definitions

Cramer, J. A., Roy, A., Burrell, A., Fairchild, C. J., Fuldeore, M. J., Ollendorf, D. A., & Wong, P. K. (2008) · Value in Health · doi:10.1111/j.1524-4733.2007.00213.x · Cited by 2,220 · see citing works

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

Coombes, R. C., Hall, E., Gibson, L. J., Paridaens, R., Jassem, J., Delozier, T., Jones, S. E., Alvarez, I., Bertelli, G., Ortmann, O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040331 · Cited by 1,759 · see citing works

A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer

The Breast International Group (BIG) 1-98 Collaborative Group (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,581 · see citing works

Interventions for helping patients to follow prescriptions for medications

Haynes, R., McDonald, H., Garg, A., & Montague, P. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011 · Cited by 911 · see citing works

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870 · see citing works

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

Hershman, D. L., Kushi, L. H., Shao, T. H., Buono, D. L., Kershenbaum, A., Tsai, W., Fehrenbacher, L., Gomez, S. L., Miles, S. Q., & Neugut, A. I. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9655 · Cited by 834 · see citing works

Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2114-5 · Cited by 708 · see citing works

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676 · see citing works

Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

Partridge, A. H., LaFountain, A., Mayer, E. L., Taylor, B. S., Winer, E. P., & Asnis-Alibozek, A. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.5451 · Cited by 483 · see citing works

Adherence to tamoxifen over the five-year course

Lash, T. L., Fox, M. P., Westrup, J., Fink, A. K., & Silliman, R. A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9193-0 · Cited by 321 · see citing works

Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.

Waterhouse, D. M., Calzone, K. A., Mele, C., & Brenner, D. E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1189 · Cited by 313 · see citing works

Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer

Owusu, C., Buist, D. S. M., Field, T. S., Lash, T. L., Thwin, S. S., Geiger, A. M., Quinn, V. P., Frost, F. J., Prout, M. N., Yood, M. U., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1022 · Cited by 304 · see citing works

Adjuvant Tamoxifen: Predictors of Use, Side Effects, and Discontinuation in Older Women

Demissie, S., Silliman, R. A., & Lash, T. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.322 · Cited by 301 · see citing works

Patient Beliefs and Tamoxifen Discontinuance in Older Women With Estrogen Receptor—Positive Breast Cancer

Fink, A. K., Gurwitz, J. H., Rakowski, W., Guadagnoli, E., & Silliman, R. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.064 · Cited by 282 · see citing works

Early discontinuation of tamoxifen

Barron, T. I., Connolly, R. M., Bennett, K., Feely, J., & Kennedy, M. J. (2007) · Cancer · doi:10.1002/cncr.22485 · Cited by 281 · see citing works

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

Ziller, V., Kalder, M., Albert, U., Holzhauer, W., Ziller, M., Wagner, U. A. G., & Hadji, P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn646 · Cited by 263 · see citing works

Adherence to endocrine therapy for breast cancer

Chlebowski, R. T., & Geller, M. L. (2006) · Oncology · doi:10.1159/000100444 · Cited by 251 · see citing works

Practical guidance for the management of aromatase inhibitor-associated bone loss

Hadji, P., Body, J. J., Aapro, M., Brufsky, A., Coleman, R. E., Guise, T. A., Lipton, A., & Tubiana-Hulin, M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn164 · Cited by 226 · see citing works

The Importance of Medication Adherence in Improving Chronic-Disease Related Outcomes

Balkrishnan, R. (2005) · Medical Care · doi:10.1097/01.mlr.0000166617.68751.5f · Cited by 167 · see citing works

Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer

Dezentjé, V. O., van Blijderveen, N. J. C., Gelderblom, H., Putter, H., van Herk-Sukel, M. P. P., Casparie, M. K., Egberts, A. C. G., Nortier, J. W. R., & Guchelaar, H.-J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0894 · Cited by 163 · see citing works

Using motivational interviewing to promote adherence to antiretroviral medications: A randomized controlled study

DiIorio, C. K., McCarty, F., Resnicow, K., Holstad, M. M., Soet, J. E., Yeager, K. A., Sharma, S., Morisky, D. E., & Lundberg, B. E. (2008) · AIDS Care · doi:10.1080/09540120701593489 · Cited by 160 · see citing works

A 2-Arm, Randomized, Controlled Trial of a Motivational Interviewing-Based Intervention to Improve Adherence to Antiretroviral Therapy (ART) Among Patients Failing or Initiating ART

Golin, C. E., Earp, J. A., Tien, H. C., Stewart, P. W., Porter, C. Q., & Howie, L. J. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000219771.97303.0a · Cited by 144 · see citing works

Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy

Hadji, P. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.02.001 · Cited by 133 · see citing works

Improving Adherence Persistence: A Review Assessment of Interventions Description of Steps Toward a National Adherence Initiative

Krueger, K. P., Felkey, B. G., & Berger, B. A. (2003) · Journal of the American Pharmacists Association · doi:10.1331/154434503322642598 · Cited by 120 · see citing works

Non-adherence to endocrine therapy for breast cancer

Partridge, A. H. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj141 · Cited by 55 · see citing works

Acceptance of adjuvant therapy and quality of life issues

Fallowfield, L. J. (2005) · The Breast · doi:10.1016/j.breast.2005.08.012 · Cited by 53 · see citing works

Adherence with adjuvant hormonal therapy for breast cancer

Ruddy, K. J., & Partridge, A. H. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp039 · Cited by 37 · see citing works

Patients' Understanding of and Compliance With Medications: The Sixth Vital Sign?

Rosenow, E. C. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.8.983 · Cited by 34 · see citing works

Assessment of Psychological Factors Associated with Adherence to Medication Regimens Among Adult Patients with Asthma

Schmaling, K. B., Afari, N., & Blume, A. W. (2000) · Journal of Asthma · doi:10.3109/02770900009055457 · Cited by 22 · see citing works

Kurzfassung der aktualisierten Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland 2008

Albert, U., Altland, H., Duda, V., Engel, J., Geraedts, M., Heywang-Köbrunner, S., Hölzel, D., Kalbheim, E., Koller, M., König, K., et al. (2008) · RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · doi:10.1055/s-2008-1027320 · Cited by 8 · see citing works

HPI MEDICAID DRUG SPENDING AFTER THE MEDICARE MODERNIZATION ACT: WHAT WILL BE LEFT?

Boulanger, L., Brown, J., & Menzin, J. (2005) · Value in Health · doi:10.1111/j.1524-4733.2005.08302.x · Cited by 1 · see citing works

Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations

Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397 · see citing works

A Systematic Review of Adherence to Oral Antineoplastic Therapies

Greer, J. A., Amoyal, N. R., Nisotel, L. E., Fishbein, J. N., MacDonald, J. J., Stagl, J. M., Lennes, I. T., Temel, J. S., Safren, S. A., & Pirl, W. F. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0405 · Cited by 351 · see citing works

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence

Chirgwin, J. H., Giobbie-Hurder, A., Coates, A. S., Price, K. N., Ejlertsen, B., Debled, M., Gelber, R. D., Goldhirsch, A., Smith, I., Rabaglio, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.8619 · Cited by 244 · see citing works

Adherence to Endocrine Therapy in Breast Cancer Adjuvant and Prevention Settings

Chlebowski, R. T., Kim, J., & Haque, R. (2014) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0389 · Cited by 191 · see citing works

Patient-reported factors associated with adherence to adjuvant endocrine therapy after breast cancer: an integrative review

Lambert, L. K., Balneaves, L. G., Howard, A. F., & Gotay, C. C. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4561-5 · Cited by 126 · see citing works

Contributors to nonadherence and nonpersistence with endocrine therapy in breast cancer survivors recruited from an online research registry

Stanton, A. L., Petrie, K. J., & Partridge, A. H. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2961-3 · Cited by 109 · see citing works

Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trial

Graetz, I., McKillop, C. N., Stepanski, E., Vidal, G. A., Anderson, J. N., & Schwartzberg, L. S. (2018) · Journal of Cancer Survivorship · doi:10.1007/s11764-018-0682-z · Cited by 106 · see citing works

Systematic review of real-world studies evaluating the impact of medication non-adherence to endocrine therapies on hard clinical endpoints in patients with non-metastatic breast cancer

Inotai, A., Ágh, T., van Maris, R. F., Erdősi, D., Kovács, S., Kaló, Z., & Senkus, E. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102264 · Cited by 82 · see citing works

Behavioral interventions to enhance adherence to hormone therapy in breast cancer survivors: a systematic literature review

Hurtado-de-Mendoza, A., Cabling, M. L., Lobo, T., Dash, C., & Sheppard, V. B. (2016) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.03.006 · Cited by 79 · see citing works

Interventions to Enhance Adherence to Oral Antineoplastic Agents: A Scoping Review

Rosenberg, S. M., Petrie, K. J., Stanton, A. L., Ngo, L. D., Finnerty, E. K., & Partridge, A. H. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz244 · Cited by 82 · see citing works

Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105

Hershman, D. L., Unger, J. M., Hillyer, G. C., Moseley, A. B., Arnold, K. B., Dakhil, S. R., Esparaz, B. T., Kuan, M. C., Graham, M. L., Lackowski, D. M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02699 · Cited by 75 · see citing works

A Systematic Review and Meta-Analysis of Interventions to Promote Adjuvant Endocrine Therapy Adherence Among Breast Cancer Survivors

Bright, E. E., Finkelstein, L. B., Nealis, M. S., Genung, S. R., Wrigley, J., Gu, H. C. J., Schmiege, S. J., & Arch, J. J. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00697 · Cited by 74 · see citing works

Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy

Kimmick, G., Edmond, S. N., Bosworth, H. B., Peppercorn, J., Marcom, P. K., Blackwell, K., Keefe, F. J., & Shelby, R. A. (2015) · The Breast · doi:10.1016/j.breast.2015.06.010 · Cited by 72 · see citing works

Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence

Heisig, S. R., Mora, M. C. S., von Blanckenburg, P., Schuricht, F., Rief, W., Albert, U., & Nestoriuc, Y. (2014) · Psycho-Oncology · doi:10.1002/pon.3611 · Cited by 72 · see citing works

A systematic review of interventions to improve adherence to endocrine therapy

Heiney, S. P., Parker, P. D., Felder, T. M., Adams, S. A., Omofuma, O. O., & Hulett, J. M. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-018-5012-7 · Cited by 69 · see citing works

Interventions to promote adherence to endocrine therapy among breast cancer survivors: a meta-analysis

Finitsis, D. J., Vose, B. A., Mahalak, J. G., & Salner, A. L. (2019) · Psycho-Oncology · doi:10.1002/pon.4959 · Cited by 68 · see citing works

Preference for and understanding of graphs presenting health risk information. The role of age, health literacy, numeracy and graph literacy

van Weert, J. C. M., Alblas, M. C., van Dijk, L., & Jansen, J. (2020) · Patient Education and Counseling · doi:10.1016/j.pec.2020.06.031 · Cited by 67 · see citing works

Acceptability and feasibility of a self-management intervention for women prescribed tamoxifen

Moon, Z., Moss-Morris, R. E., Hunter, M. S., Goodliffe, S., & Hughes, L. D. (2019) · Health Education Journal · doi:10.1177/0017896919853856 · Cited by 66 · see citing works

Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?

Ekinci, E., Nathoo, S., Korattyil, T., Vadhariya, A., Zaghloul, H. A., Niravath, P. A., Abughosh, S., & Trivedi, M. V. (2018) · Journal of Cancer Survivorship · doi:10.1007/s11764-017-0674-4 · Cited by 65 · see citing works

Running away from side effects: physical exercise as a complementary intervention for breast cancer patients

Casla, S., Højman, P., Márquez‐Rodas, I., López‐Tarruella, S., Jerez, Y., Barakat, R., & Martín, M. (2014) · Clinical & Translational Oncology · doi:10.1007/s12094-014-1184-8 · Cited by 64 · see citing works

Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study

Nabieva, N., Fehm, T. N., Häberle, L., Waal, J. D., Rezai, M., Baier, B., Baake, G., Kolberg, H., Guggenberger, M., Warm, M. R., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.03.020 · Cited by 53 · see citing works

Motivating Patient Adherence to Allergic Rhinitis Treatments

Bender, B. G. (2015) · Current Allergy and Asthma Reports · doi:10.1007/s11882-014-0507-8 · Cited by 48 · see citing works

Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study

Harborg, S., Heide‐Jørgensen, U., Ahern, T. P., Ewertz, M., Cronin-Fenton, D. P., & Borgquist, S. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05749-5 · Cited by 47 · see citing works

The Special Challenge of Nonadherence With Sublingual Immunotherapy

Bender, B. G., & Oppenheimer, J. J. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.01.003 · Cited by 45 · see citing works

Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study

Hagen, K. B., Aas, T., Kvaløy, J. T., Søiland, H., & Lind, R. A. (2019) · The Breast · doi:10.1016/j.breast.2019.01.003 · Cited by 45 · see citing works

A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial

Jacobs, J. M., Post, K. E., Massad, K., Horick, N., Walsh, E. A., Cohn, J. G., Rapoport, C. S., Clara, A. J., Antoni, M. H., Safren, S. A., et al. (2022) · Cancer · doi:10.1002/cncr.34409 · Cited by 41 · see citing works

Effect of a Smart Pill Bottle Reminder Intervention on Medication Adherence, Self-efficacy, and Depression in Breast Cancer Survivors

Park, H. R., Kang, H. S., Kim, S. H., & Singh‐Carlson, S. (2021) · Cancer Nursing · doi:10.1097/ncc.0000000000001030 · Cited by 41 · see citing works

Bidirectional Text Messaging to Monitor Endocrine Therapy Adherence and Patient-Reported Outcomes in Breast Cancer

Mougalian, S. S., Epstein, L. N., Jhaveri, A. P., Han, G., Abu-Khalaf, M. M., Hofstatter, E. W., DiGiovanna, M. P., Silber, A. L. M., Adelson, K. B., Pusztai, L., et al. (2017) · JCO Clinical Cancer Informatics · doi:10.1200/cci.17.00015 · Cited by 39 · see citing works

Remote Monitoring App for Endocrine Therapy Adherence Among Patients With Early-Stage Breast Cancer

Graetz, I., Hu, X. Y., Koçak, M., Krukowski, R. A., Anderson, J. N., Waters, T. M., Curry, A. N., Robles, A., Paladino, A. J., Stepanski, E. J., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.17873 · Cited by 37 · see citing works

Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada

Blanchette, P., Lam, M., Richard, L., Allen, B. N., Shariff, S. Z., Vandenberg, T. A., Pritchard, K. I., Chan, K., Louie, A. V., Desautels, D. N., et al. (2019) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05430-6 · Cited by 32 · see citing works

Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy

Green, S. M. C., French, D., Graham, C. D., Hall, L., Rousseau, N. S., Foy, R., Clark, J., Parbutt, C., Raine, E., Gardner, B., et al. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08243-4 · Cited by 31 · see citing works

Fatores associados à adesão e à persistência na hormonioterapia em mulheres com câncer de mama

Guedes, J. B. R., Guerra, M. R., Alvim, M. M., & Leite, I. C. G. (2017) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-5497201700040007 · Cited by 28 · see citing works

Women’s Beliefs on Early Adherence to Adjuvant Endocrine Therapy for Breast Cancer: A Theory-Based Qualitative Study to Guide the Development of Community Pharmacist Interventions

Humphries, B., Collins, S., Guillaumie, L., Lemieux, J., Dionne, A. R., Provencher, L., Moisan, J., & Lauzier, S. (2018) · Pharmacy · doi:10.3390/pharmacy6020053 · Cited by 27 · see citing works

THRIVE study protocol: a randomized controlled trial evaluating a web-based app and tailored messages to improve adherence to adjuvant endocrine therapy among women with breast cancer

Paladino, A. J., Anderson, J. N., Krukowski, R. A., Waters, T. M., Koçak, M., Graff, J. C., Blue, R., Jones, T. N., Buzaglo, J. S., Vidal, G. A., et al. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4588-x · Cited by 27 · see citing works

Adherence to Adjuvant Endocrine Therapy in Christchurch Women with Early Breast Cancer

Robinson, B. A., Dijkstra, B., Davey, V., Tomlinson, S., & Frampton, C. M. (2017) · Clinical Oncology · doi:10.1016/j.clon.2017.10.015 · Cited by 25 · see citing works

Development of a self-management intervention to improve tamoxifen adherence in breast cancer survivors using an Intervention Mapping framework

Moon, Z., Moss-Morris, R. E., Hunter, M. S., & Hughes, L. D. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05850-x · Cited by 22 · see citing works

Investigation of Intervention Solutions to Enhance Adherence to Oral Anticancer Medicines in Adults: Overview of Reviews

Dang, T. H., Forkan, A. R. M., Wickramasinghe, N. S., Jayaraman, P. P., Alexander, M., Burbury, K., & Schofield, P. E. (2022) · JMIR Cancer · doi:10.2196/34833 · Cited by 22 · see citing works

Adherence to Adjuvant Endocrine Therapy for Breast Cancer: Importance in Women with Low Income

Ursem, C. J., Bosworth, H. B., Shelby, R. A., Hwang, W., Anderson, R. T., & Kimmick, G. G. (2015) · Journal of Women s Health · doi:10.1089/jwh.2014.4982 · Cited by 21 · see citing works

Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial

Sanft, T. B., Harrigan, M., Cartmel, B., Ferrucci, L. M., Li, F., McGowan, C. J., Zupa, M., Nguyen, T. H., Ligibel, J. A., Neuhouser, M. L., et al. (2021) · Contemporary Clinical Trials · doi:10.1016/j.cct.2021.106508 · Cited by 19 · see citing works

Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy—results from the prospective multi-center study BRENDA II

Schwentner, L., van Ewijk, R. J. G., Kühn, T., Flock, F., Felberbaum, R., Blettner, M., Kreienberg, R., Janni, W., Wöckel, A., & Singer, S. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3088-3 · Cited by 19 · see citing works

Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET)

Shelby, R. A., Dorfman, C. S., Bosworth, H. B., Keefe, F., Sutton, L., Owen, L., Corsino, L., Erkanli, A., Reed, S. D., Arthur, S. S., et al. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2018.11.010 · Cited by 18 · see citing works

ONS Guidelines™ to Support Patient Adherence to Oral Anticancer Medications

Belcher, S. M. (2022) · Oncology nursing forum · doi:10.1188/22.onf.279-295 · Cited by 18 · see citing works

Oral anticancer agent medication adherence by outpatients

Kimura, M., Usami, E., Iwai, M., Nakao, T., Yoshimura, T., Mori, H., Sugiyama, T., & Teramachi, H. (2014) · Oncology Letters · doi:10.3892/ol.2014.2480 · Cited by 18 · see citing works

Why individual‐level interventions are not enough: Systems‐level determinants of oral anticancer medication adherence

Dean, L. T., George, M., Lee, K. T., & Ashing, K. T. (2020) · Cancer · doi:10.1002/cncr.32946 · Cited by 18 · see citing works

Brief relaxation training is associated with long-term endocrine therapy adherence among women with breast cancer: post hoc analysis of a randomized controlled trial

Ream, M. E., Walsh, E. A., Jacobs, J. M., Taub, C. J., Lippman, M. E., Solle, N. S., Safren, S. A., & Antoni, M. H. (2021) · Breast Cancer Research and Treatment · doi:10.1007/s10549-021-06361-x · Cited by 17 · see citing works

Endocrine therapy adherence: a cross-sectional study of factors affecting adherence and discontinuation of therapy

Quinn, E. M., Fleming, C., & O’Sullivan, M. J. (2015) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-015-1307-4 · Cited by 17 · see citing works

Impact of telehealth interventions on physiological and psychological outcomes in breast cancer survivors: A meta-analysis of randomised controlled trials

Ajmera, P., Miraj, M., Kalra, S., Goyal, R. K., Chorsiya, V., Shaik, R. A., Alzhrani, M., Alanazi, A., Alqahtani, M., Miraj, S. A., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1017343 · Cited by 16 · see citing works

Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review

Yang, S., Park, S. W., Bae, S. J., Ahn, S. G., Jeong, J., & Park, K. (2023) · Journal of Breast Cancer · doi:10.4048/jbc.2023.26.e22 · Cited by 15 · see citing works

Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program

Vacher, L., Thivat, É., Poirier, C., Mouret‐Reynier, M., Chollet, P. J. M., Devaud, H., Dubray‐Longeras, P., Kwiatkowski, F., Durando, X., Praagh-Doreau, I. V., et al. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-05144-x · Cited by 15 · see citing works

Improving Adherence to Adjuvant Endocrine Therapy in Breast Cancer Through a Therapeutic Educational Approach: A Feasibility Study

Bourmaud, A., Rousset, V., Denois, V. R., Collard, O., Jacquin, J.-P., Merrouche, Y., Lapoirie, J., Tinquaut, F., Lataillade, L., & Chauvin, F. (2016) · Oncology nursing forum · doi:10.1188/16.onf.e94-e103 · Cited by 14 · see citing works

Treatment Decisions and Adherence to Adjuvant Endocrine Therapy in Breast Cancer

Wassermann, J., & Rosenberg, S. M. (2017) · Current Breast Cancer Reports · doi:10.1007/s12609-017-0248-5 · Cited by 14 · see citing works

Effects of a nurse-led medication self-management programme in cancer patients: protocol for a mixed-method randomised controlled trial

Komatsu, H., Yagasaki, K., & Yamaguchi, T. (2016) · BMC Nursing · doi:10.1186/s12912-016-0130-1 · Cited by 14 · see citing works

Development of a community pharmacy-based intervention to enhance adherence to adjuvant endocrine therapy among breast cancer survivors guided by the Intervention Mapping approach

Labonté, M., Guillaumie, L., Dionne, A. R., Dorval, M., Nabi, H., Lemieux, J., Provencher, L., & Lauzier, S. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.02.004 · Cited by 13 · see citing works

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life

Stewart, S.-J., Slodkowska‐Barabasz, J., Hackshaw‐McGeagh, L., Moon, Z., Brett, J., Wells, M., Brown, M. C., Turner, M., Horne, R., Fenlon, D., et al. (2023) · The Breast · doi:10.1016/j.breast.2023.05.007 · Cited by 13 · see citing works

A qualitative comparison of how older breast cancer survivors process treatment information regarding endocrine therapy

Pieters, H. C., Green, E., Khakshooy, S., Sleven, M., & Stanton, A. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210972 · Cited by 12 · see citing works

Development of a Smartphone Program to Support Adherence to Oral Chemotherapy in People with Cancer

Ross, X. S., Gunn, K. M., Patterson, P., & Olver, I. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s225175 · Cited by 10 · see citing works

Patient experience of taking adjuvant endocrine therapy for breast cancer: a tough pill to swallow

Wen, K., Smith, R. F., Padmanabhan, A., & Goldstein, L. J. (2017) · Patient Experience Journal · doi:10.35680/2372-0247.1173 · Cited by 9 · see citing works

When can cancer patient treatment nonadherence be considered intentional or unintentional? A scoping review

Wreyford, L., Gururajan, R., & Zhou, X. (2023) · PLoS ONE · doi:10.1371/journal.pone.0282180 · Cited by 8 · see citing works

Validação de Materiais Educativos para Orientação de Pacientes em Tratamento de Câncer de Mama com Hormonioterapia

Sugisaka, A. C. A., Andrzejevski, V. M. S., & Rotta, I. (2020) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2020v66n4.1079 · Cited by 8 · see citing works

“Interventions to increase adherence to oral therapies in breast cancer patients: A systematic review based on the behavior change technique taxonomy”

Pezzolato, M., Marzorati, C., Lanzoni, L., Monzani, D., Masiero, M. A., Pietrobon, R. S., & Pravettoni, G. (2023) · Psycho-Oncology · doi:10.1002/pon.6203 · Cited by 8 · see citing works

Treatment persistence and hospitalization rates among patients with schizophrenia: a quasi-experiment to evaluate a patient information program

Pilon, D., Amos, T. B., Germain, G., Lafeuille, M., Lefèbvre, P., & Benson, C. J. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1277989 · Cited by 7 · see citing works

Identification of patient subgroups who benefit from a behavioral intervention to improve adjuvant endocrine therapy adherence: a randomized-controlled trial

Walsh, E. A., Post, K. E., Massad, K., Horick, N., Antoni, M. H., Penedo, F. J., Safren, S. A., Partridge, A. H., Peppercorn, J. M., Park, E. R., et al. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-023-07228-z · Cited by 6 · see citing works

Effect of telehealth interventions on adherence to endocrine therapy among patients with breast cancer: a systematic review and meta-analysis

Sun, S., Zhang, B., Zhang, N., Zhang, Y., Zhu, M., & Zhang, M. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08339-z · Cited by 5 · see citing works

Beliefs about medicines’ association with endocrine therapy adherence in early breast cancer survivors in Croatia

Okroša, A. D., Silovski, T., Plavetić, N. D., Silovski, H., Kovačić, A., & Mucalo, I. (2023) · Acta Pharmaceutica · doi:10.2478/acph-2023-0043 · Cited by 4 · see citing works

Information Support Provided by Specialized Nurses via Mobile Healthcare App May Improve Treatment Adherence of Breast Cancer Patients: An Observational Study

Dong, X., Yu, J., Nie, L., Wu, Y., Lu, Y., Qin, Y., Jin, Y., Chen, Y., Gu, C., Gan, L., et al. (2023) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2023.151511 · Cited by 4 · see citing works

Associations of pretreatment emotional distress with adherence to therapy for patients with locally advanced rectal cancer: a post hoc analysis of the Chinese FOWARC phase 3 randomized clinical trial

Shi, L., Zhang, J., & Deng, Y. (2025) · BMC Medicine · doi:10.1186/s12916-025-04128-5 · Cited by 3 · see citing works

Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial

Kamga, A. M., Martino, C. D., Anota, A., Paget‐Bailly, S., Coutant, C., Arveux, P., Desmoulins, I., & Dabakuyo‐Yonli, T. S. (2020) · Trials · doi:10.1186/s13063-020-04397-w · Cited by 3 · see citing works

Active symptom monitoring for premenopausal women with breast cancer initiating adjuvant endocrine therapy: Protocol for the SWOG S2010 randomized controlled efficacy trial

Henry, N. L., Unger, J. M., Vaidya, R., Darke, A. K., Skaar, T. C., Fisch, M. J., & Hershman, D. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107712 · Cited by 2 · see citing works

Effects of a Medication Adherence Promotion Program in Breast Cancer Patients under Adjuvant Hormonal Therapy

Yu, S. H., & Kang, J. H. (2020) · Korean Journal of Adult Nursing · doi:10.7475/kjan.2020.32.3.223 · Cited by 1 · see citing works

Influencia de un programa de ejercicio aeróbico en la calidad de vida de pacientes afectadas por cáncer de mama = Influence of an aerobic exercise program on breast cancer patients’ quality of life

Barrio, S. C. (2014) · doi:10.20868/upm.thesis.33814

A Review of the Literature Evaluating Adherence and Persistence to Adjuvant Endocrine Therapy

Strickland, K. S. (2017) · Journal of Gynecology and Womens Health · doi:10.19080/jgwh.2017.07.555725

Getting in sync with adherence to endocrine therapy in breast cancer

Manz, C. R. (2019) · Cancer · doi:10.1002/cncr.32434

Effects of a nurse-led medication self-management programme in cancer patients: a mixed-method randomised controlled trialPreprint

Komatsu, H., Yagasaki, K., Yamaguchi, T., Mori, A., Kawano, H., Minamoto, N., Honma, O., & Tamura, K. (2019) · doi:10.21203/rs.2.16889/v1

Beliefs, attitudes and acceptance towards an eHealth tool to support oral hormonal therapy in breast cancer: A qualitative study. (Preprint)Preprint

Goetzinger, C., Bendiane, M., Rauh, S., Duhem, C., Jodocy, D., Préau, M., Vrijens, B., Mancini, J., Untereiner, M., Fagherazzi, G., et al. (2020) · doi:10.2196/preprints.26100

Network Modeling of Complex Time-Dependent Changes in Patient Adherence to Adjuvant Endocrine Treatment in ER+ Breast Cancer

Shinn, E. H., Busch, B. E., Jasemi, N., Lyman, C. A., Toole, J. T., Richman, S., Symmans, W. F., Chávez‐MacGregor, M., Peterson, S. K., & Broderick, G. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.856813

Desenvolvimento e Validação de Material Educativo para Orientação do Uso do Succinato de Ribociclibe no Tratamento do Câncer de Mama Avançado

Silva, B. P., Lima, T. M. B., Veloso, S. A., Silva, J., Sousa, C. M., de Lima, P. A., Pinheiro, A. N., de Andrade, C. C., & de Sousa, J. A. C. (2025) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2026v72n1.5350

Additional file 2 of Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy

Green, S. M. C., French, D., Graham, C. D., Hall, L., Rousseau, N., Foy, R., Clark, J., Parbutt, C., Raine, E., Gardner, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20619870

Additional file 1 of Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy

Green, S. M. C., French, D., Graham, C. D., Hall, L., Rousseau, N., Foy, R., Clark, J., Parbutt, C., Raine, E., Gardner, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20619867

Additional file 4 of Supporting adjuvant endocrine therapy adherence in women with breast cancer: the development of a complex behavioural intervention using Intervention Mapping guided by the Multiphase Optimisation Strategy

Green, S. M. C., French, D., Graham, C. D., Hall, L., Rousseau, N., Foy, R., Clark, J., Parbutt, C., Raine, E., Gardner, B., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20619876

Impact de la voie d'administration des anticancéreux sur la qualité de vie des patients : rôles des processus transactionnels et bénéfices d'une éducation thérapeutique

Dhellemmes, A. (2019) · theses.fr (ABES) · doi:10.70675/663e49e6zd85az4783z9df4z1a6e51e991a7

Desarrollo y Validación de Material Educativo para la Orientación sobre el Uso de Succinato de Ribociclib en el Tratamiento del Cáncer de Mama Avanzado

Silva, B. P., Lima, T. M. B., Veloso, S. A., da Silva, J. S., Sousa, C. M., de Lima, P. A., Pinheiro, A. N., de Andrade, C. C., & de Sousa, J. A. C. (2026) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2026v72n1.5350es

Endocrine therapy and cataract risk in breast cancer survivors: a systematic review and meta-analysis integrating adjusted real-world and randomized evidencePreprint

Yue, M., Li, P., Lu, X., Yi, Y., & Yi, L. (2026) · Research Square · doi:10.21203/rs.3.rs-10324462/v1

A prospective, multicenter, controlled, observational study to evaluate the efficacy of a patient support program in improving patients’ persistence to adjuvant aromatase inhibitor medication for postmenopausal, early stage breast cancer

Yu, K.-D., Zhou, Y., Liu, G.-Y., Li, B., He, P.-Q., Zhang, H.-W., Lou, L.-H., Wang, X.-J., Wang, S., Tang, J.-H., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2059-8 · Cited by 50 · see citing works

The patient’s anastrozole compliance to therapy (PACT) program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer

Hadji, P., Blettner, M., Harbeck, N., Jackisch, C., Lück, H.-J., Windemuth-Kieselbach, C., Zaun, S., & Kreienberg, R. (2013) · Annals of Oncology · doi:10.1093/annonc/mds653 · Cited by 122 · see citing works

Einfluss eines schriftlichen oder mündlichen Patientienteninformationsprogrammes auf die Compliance mit einem Aromatasehemmer in der adjuvanten Therapie des Mammakarzinoms im Vergleich zur Standardaufklärung – Ergebnisse der COMPAS-Studie

Ziller, V., Kyvernitakis, I., Storch, A., Müller, H., Albert, U., Wagner, U., & Hadji, P. (2011) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0031-1286429 · Cited by 1 · see citing works

Abstract P5-11-06: Impact of Educational Material on Compliance and Persistence Rates with Adjuvant Aromatase Inhibitors: First Year Data in Patients Recruited in France (CARIATIDE STUDY)

Serin, D., Clippe, S., Resbeut, M., Radji, A., Jovenin, N., Benoît, C., Spaëth, D., Puyuelo, L., Jaubert, D., Cowen, D. M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.sabcs10-p5-11-06

The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of ARomatase inhibitors AssessmenT in daily practice through educational approach (CARIATIDE) study

Neven, P., Markopoulos, C., Tanner, M., Marty, M., Kreienberg, R., Atkins, L., Franquet, A., Gnant, M., Neciosup, S., Tesarova, P., et al. (2014) · The Breast · doi:10.1016/j.breast.2014.02.009 · Cited by 53 · see citing works